Viewing nowLosartan 100 mg (Losartan Potassium)
Losartan Potassium 1000mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

MFDS item code 201507876 · Approved 2015.11.25 · Insurance code 669501670
Treatment of kidney disease in patients with hypertension and type 2 diabetes mellitus accompanied by hypertension
This medication is used to treat high blood pressure. It is particularly effective in preventing and treating kidney diseases in patients with type 2 diabetes among those with high blood pressure. It helps to stabilize blood pressure, reducing the risk of cardiovascular diseases and protecting kidney function. Thus, it plays an important role in managing complications associated with hypertension. This medication is used to treat kidney disease in patients with hypertension and diabetes.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Older adults No initial dose adjustment is necessary in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. (2) Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced effective circulating blood volume For patients who may have reduced effective circulating blood volume (intravascular volume depletion) (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
2) Pediatric and adolescent patients aged 6 years and older (1) Patients weighing 20 kg or more and less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. (2) Patients weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. (3) This medicine is not recommended for pediatric patients under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication may cause serious harm to the fetus if taken by pregnant women, particularly in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with severely impaired liver function, certain genetic disorders, or specific cardiovascular diseases. Elderly patients, those with weakened kidney function, and patients at risk for hyperkalemia should use this medication with special caution and regular monitoring to ensure that blood pressure does not drop too low. During the course of this medication, blood pressure, kidney function, electrolyte levels, etc., should be monitored periodically for any abnormal signs. Caution is advised to avoid concomitant use with potassium supplements or medications containing potassium, as it may dangerously raise serum potassium levels. This medication may occasionally cause side effects such as headache, dizziness, muscle cramps, cough, dyspepsia, etc. If severe allergic reactions or angioedema occur, discontinue use immediately and seek medical attention. Babies exposed to this medication in utero may experience serious problems such as hypotension, kidney function degradation, and cranial formation issues, so if pregnancy is confirmed, use should be discontinued immediately. It is advisable that breastfeeding women do not take this medication, and if unavoidable, breastfeeding should be discontinued. This medication is not recommended for children, especially those under 6 years of age or those with severely impaired kidney function. In the case of overdose, hypotension and bradycardia may occur, so immediate treatment at a medical facility is necessary. Caution is needed when taking this medication as dizziness or drowsiness may occur, affecting tasks requiring concentration such as driving or operating machinery. This medication may have reduced efficacy if taken with grapefruit juice, so it is advisable to avoid grapefruit juice during treatment.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1°C and 30°C. This will help preserve the medication's effectiveness and safety for a long time.
White, droplet-shaped film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 1000mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.